Skip to main content

Table 4 Disease free and overall survival rate at 4, 48 years in patients with positive staining vs. patients with negative staining for receptors of Growth Hormone.

From: Detection of somatostatin receptors in human osteosarcoma

 

Patients with Positive staining for receptors of Growth Hormone

(Frequency/Percent)

Patients with Negative staining for receptors of Growth Hormone

(Frequency/Percent)

NED

(No Evident Disease)

0/0,0

18/72,0

Disease progression

2/50,0

1/4,0

DOD

(Died On Disease)

2/50,0

6/24,0

Total

4/100,0

25/100,0